Skip to main content

Table 1 Participant demographic information

From: Liquid biopsy, using a novel DNA methylation signature, distinguishes pancreatic adenocarcinoma from benign pancreatic disease

Characteristic

Malignant (n = 19)

Benign (n = 44)

Treated (n = 9)

 

No

 

%

No

 

%

No

 

%

Age, years

         

Median

 

67

  

75

  

71

 

Range

 

47–80

  

39–93

  

60–75

 

Sex

         

Male

17

 

89

20

 

45

6

 

67

Female

2

 

11

24

 

55

3

 

33

Disease Type

         

Pancreatic Ductal Adenocarcinoma (stage IV)

19

 

100

 

9

 

100

Benign Pancreatic Cyst

 

44

 

100

 

CA 19–9 (U/mL)

         

Median

 

1173

  

NA

  

1769

 

Range

 

3–56,534

  

NA

  

14–72,745

 

Tumor Burden (cm)

         

Median

 

10.5

  

  

NA

 

Range

 

0–27.4

  

  

NA

 

Number of Metastatic Sites

         

Median

 

2

  

  

NA

 

Range

 

1–5

  

  

NA

 

Number of Lymph Nodes

         

Median

 

2

  

  

NA

 

Range

 

0–7

  

  

NA